Treatment Strategies for Tardive Dyskinesia.
Publication/Presentation Date
12-24-2019
Abstract
Tardive dyskinesia (TD), a condition of potentially irreversible abnormal involuntary movements that is associated with dopamine receptor blocking agents (DRBAs), produces significant impairment of functioning and quality of life for patients. Contrary to expectations, TD has not vanished despite the introduction of SGAs. Instead, changing prescription practices and increased off-label prescription of DRBAs have placed more patients than ever at risk of this potentially dangerous and disabling condition. This activity provides an overview of treatment strategies for TD as part of an individualized management plan, including DRBA medication adjustment and antidyskinetic treatment.
Volume
81
Issue
1
ISSN
1555-2101
Published In/Presented At
Kremens D. E. (2019). Treatment Strategies for Tardive Dyskinesia. The Journal of clinical psychiatry, 81(1), NU18041BR4C. https://doi.org/10.4088/JCP.NU18041BR4C
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
31880872
Department(s)
Administration and Leadership
Document Type
Article